| # | Drug | Count |
|---|---|---|
| 0 | TIRZEPATIDE | 316 |
| 1 | DULAGLUTIDE | 67 |
| 2 | EPINEPHRINE | 62 |
| 3 | ADALIMUMAB | 45 |
| 4 | ETANERCEPT | 45 |
| 5 | DUPILUMAB | 42 |
| 6 | EXENATIDE | 35 |
| 7 | METFORMIN | 28 |
| 8 | METFORMIN ER 500 MG | 28 |
| 9 | METFORMIN ER 750 MG | 28 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SIBEPRENLIMAB | 5 | 0.0073 |
| 1 | ACAMPROSATE CALCIUM | 1 | 0.0030 |
| 2 | EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT) | 1 | 0.0021 |
| 3 | TIRZEPATIDE | 316 | 0.0017 |
| 4 | GADOTERATE MEGLUMINE | 5 | 0.0013 |
| 5 | EPINEPHRINE | 62 | 0.0009 |
| 6 | DULAGLUTIDE | 67 | 0.0007 |
| 7 | NARATRIPTAN | 1 | 0.0007 |
| 8 | EXENATIDE | 35 | 0.0007 |
| 9 | ZALEPLON | 1 | 0.0006 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | GLP-1 Receptor Agonist [EPC] | 423 | 0.0009 |
| 1 | Catecholamine [EPC] | 63 | 0.0008 |
| 2 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 3 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 4 | Provitamin D2 Compound [EPC] | 13 | 0.0004 |
| 5 | PCSK9 Inhibitor [EPC] | 11 | 0.0004 |
| 6 | Gadolinium-based Contrast Agent [EPC] | 2 | 0.0004 |
| 7 | Interleukin-17A Antagonist [EPC] | 11 | 0.0003 |
| 8 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |
| 9 | Paramagnetic Contrast Agent [EPC] | 1 | 0.0002 |